Global Irbesartan (CAS 138402-11-6) Market Outlook 2016-2021

Published: Aug, 2016 | Pages: 102 | Publisher: Gen Consulting Company
Industry: Pharmaceutical | Report Format: Electronic (PDF)

Irbesartan (INN) is an angiotensin II receptor antagonist used mainly for the treatment of hypertension. It was developed by Sanofi Research (now part of Sanofi-Aventis). It is jointly marketed by Sanofi-Aventis and Bristol-Myers Squibb under the trade names Aprovel, Karvea, and Avapro.

This report provides detailed analysis of worldwide markets for Irbesartan (CAS 138402-11-6) from 2011-2015 and provides extensive market forecasts 2016-2021 by region/country and subsectors. It covers the key technological and market trends in the Irbesartan (CAS 138402-11-6) market and further lays out an analysis of the factors influencing the supply/demand for Irbesartan (CAS 138402-11-6), and the opportunities/challenges faced by industry participants. It also acts as an essential tool to companies active across the value chain and to the new entrants by enabling them to capitalize the opportunities and develop business strategies.

GCC's report, Global Irbesartan (CAS 138402-11-6) Market Outlook 2016-2021, has been prepared based on the synthesis, analysis, and interpretation of information about the global Irbesartan (CAS 138402-11-6) market collected from specialized sources. The report covers key technological developments in the recent times and profiles leading players in the market and analyzes their key strategies. The competitive landscape section of the report provides a clear insight into the market share analysis of key industry players. The major players in the global Irbesartan (CAS 138402-11-6) market are Sanofi (France), Taj Pharmaceuticals (India),Unichem Laboratories (India), Divis Laboratories (India), Zhejiang Tianyu (China), Zhuhai Rundu (China), Zhejiang Kinglyuan (China), among others.

The report provides separate comprehensive analytics for the North America, Europe, Asia-Pacific, Middle East and Africa and Rest of World. In this sector, global competitive landscape and supply/demand pattern of Irbesartan (CAS 138402-11-6) industry has been provided.

 Table of Contents

Part 1. Scope of Report
1.1 Methodology
1.2 Geographic Scope
1.3 Years Considered

Part 2. Introduction
2.1 Definition
2.2 Current Scenario
2.2 Future Scenario

Part.3 Value Chain Analysis
3.1 Upstream
3.2 Downstream

Part 4. Manufacture
4.1 Manufacturing Process
4.2 Issues and Trends
4.3 Manufacturing Costs

Part 5. Worldwide Key Vendors
5.1 Company A
5.1.1 Business Overview
5.1.2 Products Offered
5.1.3 Business Performance
5.2 Company B
5.3 Company C
5.4 Company D
5.5 Company E
5.6 Company F
5.7 Company G
5.8 Company H
5.9 Company I
5.10 Company J

Part 6. Market Overview
6.1 Global Production Volume 2011-2016
6.2 Production Volume by Region 2011-2016
6.2.1 North America
6.2.2 EMEA
6.2.3 Asia-Pacific
6.2.4 ROW
6.3 Global Production Value 2011-2016
6.4 Production Value by Region
6.4.1 North America
6.4.2 EMEA
6.4.3 Asia-Pacific
6.4.4 ROW

Part 7. Consumption Pattern
7.1 Regional Consumption
7.1.1 North America
7.1.2 EMEA
7.1.3 Asia-Pacific
7.1.4 ROW
7.2 Global Consumption by Application

Part 8. Market Forecast
8.1 Market Size by Volume
8.1.1 North America
8.1.2 EMEA
8.1.3 Asia-Pacific
8.1.4 ROW
8.2 Market Size by Value
8.2.1 North America
8.2.2 EMEA
8.2.3 Asia-Pacific
8.2.4 ROW
8.3 Regional Consumption Forecast
8.3.1 North America
8.3.2 EMEA
8.3.3 Asia-Pacific
8.3.4 ROW
8.4 Consumption Forecast by Application

Part 9. Market Dynamics
9.1 Market Drivers
9.2 Market Constraints
9.3 Market Strategies

Part 10. Key Events
10.1 Mergers & Acquisitions
10.2 New Product Launches
10.3 Expansions
10.4 Other Developments

List of Tables and Figures


Figure Global Irbesartan (CAS 138402-11-6) Production Volume (Unit) 2011-2016
Figure Global Irbesartan (CAS 138402-11-6) Production Value (M USD) 2011-2016
Figure Top 10 Irbesartan (CAS 138402-11-6) Vendors Production Volume Share 2015
Figure Top 10 Irbesartan (CAS 138402-11-6) Vendors Production Value Share 2015
Figure Regional Irbesartan (CAS 138402-11-6) Production (Unit) 2015
Figure Regional Irbesartan (CAS 138402-11-6) Production Value (M USD) 2015
Table Raw Material Materials Suppliers
Figure Global Irbesartan (CAS 138402-11-6) Consumption Pattern 2015
Figure Manufacturing Cost Structure
Figure Company A Irbesartan (CAS 138402-11-6) Products
Table Company A Financial Performance 2011-2016
Figure Company A Market Share 2011-2016
Figure Company B Irbesartan (CAS 138402-11-6) Products
Table Company B Financial Performance 2011-2016
Figure Company B Market Share 2011-2016
Figure Company C Irbesartan (CAS 138402-11-6) Products
Table Company C Financial Performance 2011-2016
Figure Company C Market Share 2011-2016
Figure Company D Irbesartan (CAS 138402-11-6) Products
Table Company D Financial Performance 2011-2016
Figure Company D Market Share 2011-2016
Figure Company E Irbesartan (CAS 138402-11-6) Products
Table Company E Financial Performance 2011-2016
Figure Company E Market Share 2011-2016
Figure Company F Irbesartan (CAS 138402-11-6) Products
Table Company F Financial Performance 2011-2016
Figure Company F Market Share 2011-2016
Figure Company G Irbesartan (CAS 138402-11-6) Products
Table Company G Financial Performance 2011-2016
Figure Company G Market Share 2011-2016
Figure Company H Irbesartan (CAS 138402-11-6) Products
Table Company H Financial Performance 2011-2016
Figure Company H Market Share 2011-2016
Figure Company I Irbesartan (CAS 138402-11-6) Products
Table Company I Financial Performance 2011-2016
Figure Company I Market Share 2011-2016
Figure Company J Irbesartan (CAS 138402-11-6) Products
Table Company J Financial Performance 2011-2016
Figure Company J Market Share 2011-2016
Table Global Key Irbesartan (CAS 138402-11-6) Vendors Production (Unit) 2011-2016
Table Global Key Irbesartan (CAS 138402-11-6) Vendors Production Share 2011-2016
Figure Global Irbesartan (CAS 138402-11-6) Capacity & Production (Unit), Capacity Utilization 2011-2016
Figure Global Top 10 Irbesartan (CAS 138402-11-6) Vendors Production (Unit) 2011-2016
Table Global Top 10 Irbesartan (CAS 138402-11-6) Vendors Production (Unit) 2011
Table Global Top 10 Irbesartan (CAS 138402-11-6) Vendors Production (Unit) 2012
Table Global Top 10 Irbesartan (CAS 138402-11-6) Vendors Production (Unit) 2013
Table Global Top 10 Irbesartan (CAS 138402-11-6) Vendors Production (Unit) 2014
Table Global Top 10 Irbesartan (CAS 138402-11-6) Vendors Production (Unit) 2015
Table Global Top 10 Irbesartan (CAS 138402-11-6) Vendors Production (Unit) 2016
Figure Irbesartan (CAS 138402-11-6) Production Volume (Unit) 2011-2016
Table Global Production Volume (Unit) 2011-2016
Table Global Production Volume Share 2011-2016
Figure North America Irbesartan (CAS 138402-11-6) Capacity & Production (Unit)
Figure North America Production Share Trend
Figure EMEA Irbesartan (CAS 138402-11-6) Capacity & Production (Unit)
Figure EMEA Production Share Trend
Figure Asia-Pacific Irbesartan (CAS 138402-11-6) Capacity & Production (Unit)
Figure Asia-Pacific Production Share Trend
Figure ROW Irbesartan (CAS 138402-11-6) Capacity & Production (Unit)
Figure ROW Production Share Trend Change
Figure Global Irbesartan (CAS 138402-11-6) Production Value (M USD), Growth Rate
Table Global Key Irbesartan (CAS 138402-11-6) Vendors Production Value (M USD) 2011-2016
Table Global Key Irbesartan (CAS 138402-11-6) Vendors Production Value Share 2011-2016
Figure Global Top 10 Irbesartan (CAS 138402-11-6) Vendors Production Value (M USD) 2011-2016
Table Global Top 10 Irbesartan (CAS 138402-11-6) Vendors Production Value (M USD) 2011
Table Global Top 10 Irbesartan (CAS 138402-11-6) Vendors Production Value (M USD) 2012
Table Global Top 10 Irbesartan (CAS 138402-11-6) Vendors Production Value (M USD) 2013
Table Global Top 10 Irbesartan (CAS 138402-11-6) Vendors Production Value (M USD) 2014
Table Global Top 10 Irbesartan (CAS 138402-11-6) Vendors Production Value (M USD) 2015
Table Global Top 10 Irbesartan (CAS 138402-11-6) Vendors Production Value (M USD) 2016
Figure Irbesartan (CAS 138402-11-6) Prices (USD/Ton) 2016
Figure Irbesartan (CAS 138402-11-6) Gross Margin 2016
Figure Irbesartan (CAS 138402-11-6) Production Value (M USD) By Region 2011-2016
Table Global Irbesartan (CAS 138402-11-6) Production Value (M USD) 2011-2016
Table Global Irbesartan (CAS 138402-11-6) Production Value Share 2011-2016
Figure North America Production Value (M USD), Growth Rate
Figure North America Irbesartan (CAS 138402-11-6) Production Value Share Trend
Figure EMEA Production Value (M USD), Growth Rate
Figure EMEA Irbesartan (CAS 138402-11-6) Production Value Share Trend
Figure Asia-Pacific Production Value (M USD), Growth Rate
Figure Asia-Pacific Irbesartan (CAS 138402-11-6) Production Value Share Trend
Figure ROW Production Value (M USD), Growth Rate
Figure ROW Irbesartan (CAS 138402-11-6) Production Value Share Trend
Figure Global Irbesartan (CAS 138402-11-6) Consumption Volume (Unit) 2015
Table Regional Irbesartan (CAS 138402-11-6) Consumption Volume (Unit) 2011-2016
Table Regional Irbesartan (CAS 138402-11-6) Consumption Volume Share 2011-2016
Figure Irbesartan (CAS 138402-11-6) Consumption in North America 2011-2016
Figure Irbesartan (CAS 138402-11-6) Consumption in EMEA 2011-2016
Figure Irbesartan (CAS 138402-11-6) Consumption in Asia-Pacific 2011-2016
Figure Irbesartan (CAS 138402-11-6) Consumption in ROW 2011-2016
Figure Global Irbesartan (CAS 138402-11-6) Consumption Volume (Unit) 2016
Table Global Irbesartan (CAS 138402-11-6) Consumption Volume (Unit) 2011-2016
Table Global Irbesartan (CAS 138402-11-6) Consumption Volume Share 2011-2016
Figure Global Irbesartan (CAS 138402-11-6) Production (Unit) Forecast 2016-2021
Table Global Irbesartan (CAS 138402-11-6) Production (Unit) 2016-2021
Table Global Irbesartan (CAS 138402-11-6) Production Share 2016-2021
Figure North Irbesartan (CAS 138402-11-6) Production (Unit) Forecast 2016-2021
Figure EMEA Irbesartan (CAS 138402-11-6) Production (Unit) Forecast 2016-2021
Figure Asia-Pacific Irbesartan (CAS 138402-11-6) Production (Unit) Forecast 2016-2021
Figure ROW Irbesartan (CAS 138402-11-6) Production (Unit) Forecast 2016-2021
Figure Global Irbesartan (CAS 138402-11-6) Revenue (M USD) Forecast 2016-2021
Table Global Irbesartan (CAS 138402-11-6) Revenue (M USD) 2016-2021
Table Global Irbesartan (CAS 138402-11-6) Revenue Share 2016-2021
Figure North America Irbesartan (CAS 138402-11-6) Revenue (M USD) Forecast 2016-2021
Figure EMEA Irbesartan (CAS 138402-11-6) Revenue (M USD) Forecast 2016-2021
Figure Asia-Pacific Irbesartan (CAS 138402-11-6) Revenue (M USD) Forecast 2016-2021
Figure ROW Irbesartan (CAS 138402-11-6) Revenue (M USD) Forecast 2016-2021
Figure Global Irbesartan (CAS 138402-11-6) Consumption Volume (Unit) 2016-2021
Table Global Irbesartan (CAS 138402-11-6) Consumption Volume (Unit) 2016-2021
Table Global Irbesartan (CAS 138402-11-6) Consumption Volume Share 2016-2021
Figure North America Irbesartan (CAS 138402-11-6) Consumption (Unit) Forecast
Figure EMEA Irbesartan (CAS 138402-11-6) Consumption (Unit) Forecast
Figure Asia-Pacific Irbesartan (CAS 138402-11-6) Consumption (Unit) Forecast
Figure ROW Irbesartan (CAS 138402-11-6) Consumption (Unit) Forecast
Figure Global Irbesartan (CAS 138402-11-6) Consumption Volume (Unit) 2021
Table Global Irbesartan (CAS 138402-11-6) Consumption Volume (Unit) 2016-2021
Table Global Irbesartan (CAS 138402-11-6) Consumption Volume Share 2016-2021
Table Key Strategies for Irbesartan (CAS 138402-11-6) Multinational Corporations
Table Key Strategies for Irbesartan (CAS 138402-11-6) Emerging-Market Players